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The United Nations (UN) General Assembly High Level Meeting 
(HLM) on Non-Communicable Diseases (NCDs), was held in New 
York on 19 and 20 September 2011. It provided a unique opportunity 
to prioritise NCDs as a global health challenge of enormous 
proportions, with significant societal, economic and developmental 
implications.1 This meeting focused attention on the prevention and 
control of NCDs, especially in low- and middle-income countries, 
where nearly 80% of global NCD mortality occurs. 
The priority actions identified at the HLM could lead to a sustained 
global movement against preventable death, disease and disability 
from NCDs, especially cardiovascular diseases, cancer, diabetes 
and chronic respiratory disease.2,3 Accordingly, the World Health 
Organization (WHO),4 several health professional associations5 and 
the Political Declaration6 issued at the end of the HLM on NCDs have 
all called for a strategy addressing these four diseases and their four 
shared risk factors (tobacco use, unhealthy diet, physical inactivity 
and harmful use of alcohol). 
It is well established that these major NCDs and their related 
risk factors are an urgent matter globally. Even in sub-Saharan 
Africa, where these NCDs and risk factors are not yet the leading 
causes of death or disability, trends portend a significant increase 
in NCD burden and related preventable death by 2030.7 Recent 
improvements in economic development, increasing urbanisation, 
increasing marketing of tobacco and marked shifts in dietary intake 
patterns are all likely to fuel the emergence of these chronic NCDs 
and associated mortality in Africa.8 For example, age-standardised 
prevalence of hypertension and mortality from stroke are already 
higher in Africa than in most other WHO regions.9,10 
Importantly, Ezzati et al.11 have shown that controlling 20 major 
risk factors can potentially increase healthy life expectancy by up to 
16.1 years (a 43% increase) in parts of sub-Saharan Africa.11 
However, preventing cardiovascular diseases, cancer, diabetes, 
and chronic respiratory disease – and alleviating their related risk 
factors – will not be enough. Neuropsychiatric and mental disorders 
must be prioritised as the fifth major NCD; the fifth major risk factor 
must be acknowledged as the group of infections that predispose 
to neglected tropical diseases and other NCDs, causing substantial 
chronic disability, life-long impairments and preventable death. Thus, 
the Africa agenda calls for a 5-by-5 approach. 
Mental health, neurological and 
substance use disorders in Africa
More than a decade ago, the WHO called attention to the high 
burden of disease and disability due to neuropsychiatric and mental 
disorders in Africa.12 In its regional strategy for mental health in the 
Africa Region for the years 2000 - 2010, the WHO also highlighted 
the increasing burden of poverty, natural disasters, social upheaval, 
and wars and other forms of violence as major causes of the growing 
psychosocial problems, which are often compounded by harmful use 
of alcohol and other substances.12 
In the decade since these observations, little has changed in 
much of Africa. Most African countries, except South Africa, still 
have no policies, programmes, or action plans for the prevention 
and control of neuropsychiatric disorders,13 despite projections 
that the burden of neuropsychiatric and mental disorders is likely 
to increase.7 
Recently, the extensive challenges Africa faces in preventing and 
controlling Mental health, neurological and substance use (MNS) 
disorders were highlighted again, in a workshop jointly organised by 
the US Institute of Medicine Forum on Neuroscience and Nervous 
System Disorders and the Uganda National Academy of Sciences 
Forum on Health and Nutrition.14 
MNS disorders are estimated to account for approximately 350 
million disability-adjusted life years (DALYs) lost per year in sub-
Saharan Africa — a burden that is significantly greater than that 
seen in developed countries at 150 million DALYs per year.14 Yet 
the infrastructure and manpower to address prevention, detection, 
evaluation and treatment is inadequate. 
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Most sub-Saharan African countries have 
less than 1 psychiatrist per 1 million people, 
and even fewer neurologists.15 A similarly 
grim manpower scarcity exists for psychiatric 
nurses, psychologists and trained social 
workers. Appropriate medications are scarce 
and, in the rare cases that they are available, 
access and affordability remain very limited. 
These challenges are compounded by weak 
primary healthcare and treatment systems 
and a high level of stigmatisation of mental 
health disorders, in a policy environment 
that continues to neglect NCDs.
As shown in Fig. 1, the leading psychiatric 
disorders underlying Africa’s disease burden 
include unipolar depressive disorders, post-
traumatic stress, panic disorders, bipolar 
affective disorders and schizophrenia.16 
Among the neurological disorders, by far the 
most prevalent cause of disability is epilepsy, 
typically caused by birth trauma, childhood 
infections and head injury in later life.14,16
While these MNS disorders are not 
leading causes of mortality, they do cause 
significant disability. To adequately tackle 
the inherent challenges, the UN HLM should 
facilitate substantial investments, allowing 
effective and strategic integration of mental 
healthcare into overall national health 
sector reform plans.13 Recently Jenkins et 
al.17 pointed out that it will be crucial 
to engage professionals with expertise in 
MNS disorders, and to intensively mobilise 
resources to address these disorders as 
economic and developmental challenges.17 
Although significant new resources will 
have to be invested, the absolute amount is 
not large when viewed in light of other health 
investment strategies.18 Chisholm et al. have 
shown that the cost per capita (in US dollars) 
of providing the core package of interventions 
at target coverage levels ranged from $1.85 
to $2.60 per year in low-income countries, 
compared with $3.20 to $6.25 per year in 
lower-middle-income countries.18 In a more 
recent analysis, the authors demonstrate the 
cost-effectiveness of a wide range of possible 
interventions that could be undertaken in 
sub-Saharan Africa, with the cost per year 
of healthy life varying from many multiples 
to just a fraction of average per capita 
income.19 More importantly, their data show 
that reallocating current resources to more 
cost-effective intervention strategies would 
not only save money, but also increase the 
health gain and help expand much-needed 
neuropsychiatric services in the sub-Saharan 
African setting.19
The UN HLM has a unique opportunity to 
foster a broader view of MNS disorders as a 
major cause of morbidity and an impediment 
to economic and social development in 
Africa. To do this requires: facilitating the 
development or renewal and enforcement of 
mental health legislation in Africa; working to 
secure the human rights of persons with MNS 
disorders; raising awareness and education 
about MNS disorders in order to dispel 
myths and associated stigmas; supporting 
partnerships between African national and 
international neurologic and psychiatric 
associations and their affiliation to the World 
Psychiatric Association; and identifying 
appropriate roles for traditional healers while 
supporting appropriate integration of the 
prevention and control of MNS disorders 
within the primary healthcare setting. 
To integrate mental health into national 
healthcare programmes, a pivotal step will 
be acknowledging the links between MNS 
disorders and infections since, in many 
African countries, cerebral complications 
of malaria, typhoid fever, and HIV are the 
most frequent causes of acute or subacute 
psychoses. Although typically causing only 
temporary disability, these complications 
can lead to significant disability and death 
if not promptly and adequately treated. Such 
integration would recognise the human, 
laboratory and other technical expertise 
in communicable diseases that Africa has 
developed over the past two decades and, 
importantly, would leverage them for the 
prevention and control of NCDs.
Infections as major risk 
factors for ncds in 
Africa
Infections play a primary aetiological role 
in many chronic NCDs that are endemic 
in sub-Saharan Africa, such as rheumatic 
heart disease, liver cancer, cervical cancer and 
HIV-related dementia. Taken together, these 
infections cause substantial chronic disability, 
life-long impairments and lost national 
income. It is therefore appropriate to prioritise 
them as the fifth major risk factor for the 
post-UN HLM agenda, to be addressed by the 
WHO and the public health community. 
The neglected tropical diseases (NTD) 
afflict an estimated 1 billion people, most of 
whom live in Africa and are among the poorest 
in the world,20,21 causing significant disability 
and impairing quality of life. In the Global 
Burden of Disease assessment, the major 
NTDs include trypanosomiasis, Chagas 
disease, schistosomiasis, leishmaniasis, 
lymphatic filariasis, onchocerciasis, intestinal 
nematode infections, Japanese encephalitis, 
dengue and leprosy. These accounted for an 
estimated 177 000 deaths worldwide in 2002, 
mostly in sub-Saharan Africa, and about 
20 million DALYs, or 1.3% of the global 
burden of disease and injuries.22 NTDs have 
largely been ignored on the global health 
policy agenda,23 despite effective prevention, 
treatment and control programmes. 
Recurrent streptococcal infection, the 
cause of rheumatic fever and rheumatic heart 
disease (RHD) and kidney disease, represents 
another major infectious risk factor for NCD 
in Africa. As pointed out in the Drakensberg 
Declaration,24 as many as half of the 2.4 
million children globally affected by RHD 
live in Africa, and a major proportion of all 
cardiovascular disease in children and young 
adults in Africa is attributable to rheumatic 
fever. The impact on economic productivity 
in African countries is substantial.25
Many infections are also important 
contributors to the burden and sequelae 
of major NCDs through triggering acute 
exacerbations and hospitalisations.26,27 For 
example, tuberculosis (TB) can aggravate 
blood glucose control and trigger diabetes,27 
as well as aggravating the social and financial 
stress that contributes to substance abuse 
and mental illness.28 
Fig. 1. The burden of disease from neuropsychiatric and mental disorders in the Africa Region, 2004. 
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In some settings, infections may also be causally linked to NCDs.29 
For example, malaria in pregnancy is an important cause of fetal 
malnutrition and intrauterine growth retardation in Africa, and can 
indirectly serve as a risk factor for the development of obesity, type 2 
diabetes, cardiovascular diseases and sickle cell disease.29 Appropriate 
prenatal care can therefore be an effective intervention for the 
prevention of NCDs. 
Population-wide vaccination interventions can be another effective 
strategy for NCD prevention in Africa. For example, vaccination 
against hepatitis B, a major cause of liver cancer, is now considered a 
‘best buy’ and vaccination against human papillomavirus (HPV), the 
main cause of cervical cancer, is also recommended.9 
A history of pulmonary tuberculosis (PTB) is among the leading 
causes of bronchiectasis, and a powerful risk factor for chronic 
obstructive pulmonary disease (COPD) in Africa.13 In a national 
household survey of adults in South Africa, Ehrlich et al.30 showed 
that a history of PTB is the strongest predictor of chronic bronchitis, 
with an odds ratio of 4.9 (95% CI 2.6 - 9.2) for men and 6.6 (95% 
CI 3.7 - 11.9) for women.30 While the overall prevalence of chronic 
bronchitis was 2.3% in men and 2.8% in women, the risk of chronic 
bronchitis was more strongly associated with TB than with tobacco 
smoking or exposure to smoke from biomass fuel. This suggests 
that, in Africa, PTB is a powerful risk factor for COPD.30
As previously noted, infections also play an important role in MNS 
disorders.14 
conclusion
Sub-Saharan African populations are in the midst of a health 
transition characterised by the simultaneous occurrence of epidemic 
infectious diseases and a rise in NCDs. There is direct interaction 
between infectious risk factors and chronic diseases, such as HPV 
and cervical cancer; Streptococcus pyogenes and rheumatic heart 
disease; TB and chronic lung disease; and HIV and dementia. 
The link between infectious risk factors, NCDs and 
neuropsychiatric illness has a direct bearing on the appropriate 
agenda for the prevention and control of chronic diseases in 
sub-Saharan Africa. There is a need to add the fifth risk factor 
(transmissible agents) and a fifth condition (neuropsychiatric 
illness) to the agenda for the prevention and control of NCDs in 
Africa. A 5-by-5 strategy that recognises 5 risk factors (tobacco 
smoking, unhealthy diet, physical inactivity, excessive alcohol use 
and transmissible agents) and 5 diseases (cardiovascular disease, 
chronic lung disease, diabetes, cancer and neuropsychiatric illness) is 
required to combat NCDs in sub-Saharan Africa. 
This 5-by-5 approach is consistent with the language and intent of 
the WHO Africa regional ministerial consultation on the prevention 
and control of NCDs, held in Brazzaville, Congo, in the months 
leading up to the UN HLM.31,32
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